Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AMNIOGEN
- Development stage
- Phase 4
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Intraoperative Injection, Transplantation
01
Overview
AMNIOGEN is a dehydrated human amniotic membrane allograft, a biologic product derived from human amniotic tissue. It is processed to preserve its natural properties, including moisture content, structure, and biochemical/biomechanical characteristics. This allograft is utilized in regenerative medicine for various applications such as wound healing, sports medicine, and ophthalmology. Its therapeutic effects stem from its ability to promote tissue growth and regeneration, suppress inflammation, facilitate neutrophil apoptosis, and prevent myofibroblast differentiation. AMNIOGEN provides a natural scaffold of extracellular matrix components and growth factors, supporting cellular attachment, proliferation, and differentiation to enhance the body's natural healing processes. It is manufactured by HCT Regenerative.
- Brand names
- AMNIOGENAMNIOGEN®
- Other names
- dehydrated human amniotic membrane grafthuman amniotic membrane allograft
Beyond the preview
Go deeper on AMNIOGEN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AMNIOGEN.